Advocacy intelligence hub — real-time data for patient organizations
National Institute of Allergy and Infectious Diseases (NIAID) — PHASE1
Massachusetts General Hospital — NA
Lahore University of Biological and Applied Sciences — NA
National Institute of Allergy and Infectious Diseases (NIAID) — PHASE1
Universitair Ziekenhuis Brussel — NA
Emory University — NA
Yale University — NA
National Institute of Allergy and Infectious Diseases (NIAID) — PHASE1
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Browse all Lethal ataxia with deafness and optic atrophy news →
Irini Sereti, M.D.
National Institute of Allergy and Infectious Diseases (NIAID)
📍 BETHESDA, MD
Grant Theron, PhD
University of Stellenbosch
Oleg A Shchelochkov, M.D., MD
National Human Genome Research Institute (NHGRI)
📍 IOWA CITY, IA
Clara James, PhD
HES-SO University of Applied Sciences and Arts Western Switzerland
Kathleen R Agres, PhD
National University of Singapore
Renee Heffron, PhD, MPH
University of Washington
View all Lethal ataxia with deafness and optic atrophy specialists →